The autoimmune/inflammatory syndrome induced by adjuvants (ASIA) is a recently identified
condition in which the exposure to an adjuvant leads to an aberrant autoimmune response …

The past 2 decades have seen a revolution in our approach to therapeutic
immunosuppression. We have moved from relying on broadly active traditional medications …

Objective To provide guidance to rheumatology providers on the use of COVID‐19 vaccines
for patients with rheumatic and musculoskeletal diseases (RMDs). Methods A task force was …

Objective The herpes zoster (HZ) vaccine is recommended for adults in the US ages≥ 60
years who do not have weakened immune systems. It is unclear how the risk of HZ varies …

Autoimmune diseases, including multiple sclerosis and type 1 diabetes mellitus, affect about
5% of the worldwide population. In the last decade, reports have accumulated on various …

Abstract The 2014 French Society for Rheumatology (Société Française de Rheumatologie,
SFR) recommendations about the management of rheumatoid arthritis (RA) have been …

Objective To investigate whether temporary discontinuation of methotrexate (MTX) improves
the efficacy of seasonal influenza vaccination in patients with rheumatoid arthritis (RA) …

Objective Patients with rheumatoid arthritis (RA) are at increased risk of herpes zoster, and
vaccination is recommended for patients ages 50 years and older, prior to starting treatment …

Background Immunosuppressed patients are at risk of severe viral infections-related
complications. National and international vaccination guidelines have been developed to …

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with diverse
manifestations, and its pathogenesis is unclear and complicated. Infection and SLE are …